The neuromuscular network for Canada


New pan-Canadian neuromuscular network unites doctors, researchers and patients for better research and care

Network lead Dr Hanns Lochmüller

Network lead Dr Hanns Lochmüller

A new Canadian network for neuromuscular disease was launched today in Ottawa, the home of its coordination hub. NMD4C (NMD for Canada) received catalyst funding from the Canadian Institutes of Health Research and Muscular Dystrophy Canada to develop solutions that will enable healthcare professionals, researchers and patients to work together and share expertise.

The network brings together leading neuromuscular experts from across the country who will work with patient advocacy organizations including Muscular Dystrophy Canada, Jesse’s Journey and the Ottawa-Gatineau Myotonic Dystrophy Support Group on an ambitious three-year work program. The funds will help develop vital research infrastructure resources including a unique “virtual” biobank that will enable researchers to locate the precious samples they need for their research, no matter where they are in the country, and will go towards further development of the Canadian Neuromuscular Disease Registry, a resource that enables patients to be registered for research into their condition and potential clinical trial opportunities. A new generation of specialist neuromuscular disease clinicians will receive training in best-practice care and in the cutting-edge diagnostic techniques such as genome-wide sequencing that are revolutionizing diagnosis of these genetic disorders, while young scientists will be encouraged to pursue a research career in neuromuscular disease through new placement opportunities that will enable them to see the patients their research benefits. Patients living with neuromuscular diseases will have opportunities to receive training in research and ethics methodology so that they are empowered to advocate for themselves in a research context and steer research policy towards their priorities, and will participate in updates to best-practice care guidelines that will be rolled out to all participating centres across the country.

NMD4C is coordinated from Ottawa by the CHEO Research Institute’s Dr Hanns Lochmüller, a world-renowned neuromuscular clinician-scientist who has led international networking initiatives in Europe and has a career-long commitment to collaborative science and data sharing.

Dr Lochmüller said: “We’re absolutely delighted to receive this catalyst funding for our NMD4C network. Because neuromuscular diseases are individually rare, but collectively affect many children and adults across Canada, working together, pooling expertise and developing shared infrastructure on a national level is essential if we want to make rapid progress towards giving all Canadian patients world-class care and developing new treatments. This is a fantastic opportunity for doctors, researchers and the patient community to come together to do just that, and we can’t wait to get started.”

The coordinating centre and other network sites will be recruiting staff to work on the project – see this news item for details.


Read next...


Linking clinicians and lab researchers for gene discovery: new publication on the Canadian Rare Disease Models and Mechanisms network

Over 70% of rare diseases are genetic in origin, but our understanding of the biological function of the 19,000 genes in the human genome is still often inadequate to reliably predict whether a defect in a particular gene is likely to cause a specific disease. Now that sequencing technologies that look for defects across the…

12 Lead Electrocardiogram Record Paper

New clinical care recommendations available for cardiologists treating adults with myotonic dystrophy

(le français suit) Cardiac complications may affect more than 50% of patients with myotonic dystrophy and occur in both myotonic dystrophy type 1 (DM1) and type 2 (DM2). Cardiac conduction system disturbances can have sudden and catastrophic presentations, but are often preventable through proper management. Cardiac surveillance of patients with myotonic dystrophy can therefore be…

About us

Exciting job opportunities at the NMD4C coordination office

Do you have a passion for research and care in neuromuscular diseases and the difference it can make for Canadian patients? We want you!


Walk for Muscular Dystrophy announce dates and times across Canada

Muscular Dystrophy Canada (MDC) have announced the dates and times of their annual Walk for Muscular Dystrophy in more than 40 locations across Canada.

Sign up for our newsletter



World Muscle Society 2020

The 25th International Annual Congress of the World Muscle Society takes place from 30th September – 4th October 2020, in Halifax, Nova Scotia, Canada. The...

2020 NMD4C network meeting

We are co-locating our 2020 network meeting with the MDC 2020 conference at the Sheraton Centre Toronto hotel.

OttawaNMD 2021

Save the date for OttawaNMD 2021! The uOttawa Centre for Neuromuscular Disease will host the 6th Ottawa International Conference on Neuromuscular Disease and Biology in...